Table 3.
Results of EBRT therapy.
| Patient | Primary | Field site | Dose (cGy) | Fractions | Radiation technique | Outcome | Months follow-up |
|---|---|---|---|---|---|---|---|
| 1 | PGL | R iliac fossa | 3000 | 15 | 3D conformal | Decreased pain. Stable LD, DP at 8 months | 40 |
| L pubic symphysis | 3000 | 15 | 3D conformal | ||||
| 2 | PCC | C1-C6 | 3000 | 10 | 3D conformal | Pain resolved. Stable LD, DP at 18 months | 110 |
| 3 | PGL | T6-L1 | 3000 | 10 | 3D conformal | Decreased pain. Stable LD, DP at 2.4 months | 5.9 |
| 4 | PGL | L abdomen | 4500 | 25 | 3D conformal | Decreased pain. Stable LD, DP at 7 months | 23 |
| 900 | 5 | 3D conformal | |||||
| 5 | PCC | T9-T11 | 3500 | 14 | 3D conformal | Improved pain. Stable LD, DP at 4 months | 20 |
| R femur | 2000 | 5 | 3D conformal | ||||
| 6 | PCC | L SI joint | 3500 | 14 | 3D conformal | Continued pain. Stable LD, DP 11.2 months | 7 |
| R femur | 3500 | 14 | 3D conformal | ||||
| 7 | PGL | R glomus jugulare | 1400 | 10 | Gamma Knife | Asymptomatic. Stable LD, distant CR | 56.4 |
| 8 | PGL | R skull base | 5400 | 30 | TomoTherapy | Continued symptoms. Stable LD, distant CR | 6.7 |
| 9 | PCC | Thoracic/lumbar spine | 4050 | 29 | 3D conformal | Decreased pain. Stable LD; DP at 188.1 months | 220 |
| 10 | PGL | C3 | 2400 | 1 | SRS | Asymptomatic. Stable local/distant disease | 39 |
| 11 | PGl | T3-T7 | 2000 | 8 | 3D conformal | Resolution of symptoms T3-T7; unchanged C6-T2. Stable LD, DP at 9 months | 64 |
| T3-T7 | 3600 | 18 | IMRT | ||||
| C6-T2 | 3000 | 12 | 3D conformal | ||||
| 12 | PCC | L1-L5 | 3825 | 17 | 3D conformal | Lessened pain. Stable LD, DP at 6 months | 51 |
| 13 | L hip | 3000 | 10 | 3D conformal | Pain resolved. Stable LD, DP 4.13 months | 9.9 | |
| L4 | 3000 | 10 | 3D conformal | ||||
| 14 | PCC | T10 | 2100 | 1 | IMRT | Improved pain. LP at 24 months, DP at 8 months | 33 |
| 15 | PCC | T6-T12 | 3000 | 10 | 3D conformal | Improved pain; asymptomatic at R/L femur, occipital, and frontal lobes. LP at T6-T12 at 15 months otherwise stable. DP at 2 months. | 68 |
| Sacrum | 3000 | 10 | 3D conformal | ||||
| C5-T2 | 3000 | 10 | 3D conformal | ||||
| L1-L5 | 3000 | 10 | 3D conformal | ||||
| T3-T5 | 3000 | 10 | 3D conformal | ||||
| R femur | 3000 | 10 | 3D conformal | ||||
| L femur | 3000 | 10 | 3D conformal | ||||
| T12 | 2100 | 3 | IMRT | ||||
| R mandible | 3000 | 10 | 3D conformal | ||||
| Frontal lobe | 3750 | 15 | 3D conformal | ||||
| Occipital lobe | 3750 | 15 | 3D conformal | ||||
| 16 | PCC | Porta hepatis | 2550 | 3 | FSRT | Unchanged pain, stable LD, no DP | 10 |
| 17 | PCC | L1, bilateral SI joints | 3750 | 15 | 3D conformal | Improvement in pain. Progression at L1 at 18 months, DP at 1 month | 26 |
| R hip, femur | 3000 | 10 | 3D conformal | ||||
| C4-T3 | 3000 | 10 | 3D conformal | ||||
| L hip, femur | 3000 | 10 | 3D conformal | ||||
| L4-5. Pelvis | 1800 | 9 | 3D conformal | ||||
| 18 | PCC | Organ of Zuckerkandl | 2400 | 3 | FSRT | Asymptomatic or decreased pain. LP at T11 at 3 months, DP at 0.75 month | 27 |
| T11 | 2800 | 4 | 3D conformal | ||||
| T8/T9 | 2000 | 5 | 3D conformal | ||||
| 19 | PCC | Skull base | 5000 | 25 | 3D conformal | Improved double vision. LP at C7-T12 | 5 |
| C7-T12 | 3750 | 15 | 3D conformal | ||||
| 20 | PGL | R iliac wing | 5000 | 10 | 3D conformal | Asymptomatic. Stable LD, DP 9 months | 38 |
| 21 | PCC | R clavicle | 3000 | 10 | 3D conformal | Improved pain. Stable LD, no DP | 123 |
| R hip | 3000 | 10 | 3D conformal | ||||
| 22 | PGL | L glomus jugulare | 3200 | 3D conformal | Improved pain. LP at 40.8 months, DP at 74.1 months | 74.1 | |
| 23 | PGL | T1-L2 | 4500 | 25 | 3D conformal | Asymptomatic. Stable LD, DP at 46.5 months | 128 |
| 24 | PCC | Sacrum | 3000 | 15 | 3D conformal | Improved pain. Stable LD, DP at 50 months | 69 |